Priebe and his colleagues synthesised WP1066 by modifying the structure of AG490, and WP1066 has been shown to inhibit STAT3 activity and to have a potent antitumour effect on malignant glioma cells, both in vitro and in vivo (Iwamaru et al, 2007). The gene discussed is STAT3; the disease is malignant glioma.